Proteomics of multiple sclerosis: inherent issues in defining the pathoetiology and identifying (early) biomarkers

MK Sen, MSM Almuslehi, PJ Shortland… - International Journal of …, 2021 - mdpi.com
Multiple Sclerosis (MS) is a demyelinating disease of the human central nervous system
having an unconfirmed pathoetiology. Although animal models are used to mimic the …

Update on alpha-1 antitrypsin deficiency: new therapies

DA Lomas, JR Hurst, B Gooptu - Journal of Hepatology, 2016 - Elsevier
Summary α 1-Antitrypsin deficiency is characterised by the misfolding and intracellular
polymerisation of mutant α 1-antitrypsin within the endoplasmic reticulum of hepatocytes …

Nascent chains can form co-translational folding intermediates that promote post-translational folding outcomes in a disease-causing protein

E Plessa, LP Chu, SHS Chan, OL Thomas… - Nature …, 2021 - nature.com
During biosynthesis, proteins can begin folding co-translationally to acquire their biologically-
active structures. Folding, however, is an imperfect process and in many cases misfolding …

Development of a small molecule that corrects misfolding and increases secretion of Z α1‐antitrypsin

DA Lomas, JA Irving, C Arico‐Muendel… - EMBO Molecular …, 2021 - embopress.org
Severe α1‐antitrypsin deficiency results from the Z allele (Glu342Lys) that causes the
accumulation of homopolymers of mutant α1‐antitrypsin within the endoplasmic reticulum of …

The structural basis for Z α1-antitrypsin polymerization in the liver

SV Faull, ELK Elliston, B Gooptu, AM Jagger… - Science …, 2020 - science.org
The serpinopathies are among a diverse set of conformational diseases that involve the
aberrant self-association of proteins into ordered aggregates. α1-Antitrypsin deficiency is the …

[HTML][HTML] hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in α1-antitrypsin deficiency

CP Segeritz, ST Rashid, MC de Brito, MP Serra… - Journal of …, 2018 - Elsevier
Background & Aims α 1-Antitrypsin deficiency (A1ATD) is an autosomal recessive disorder
caused by mutations in the SERPINA1 gene. Individuals with the Z variant (Gly342Lys) …

Novel SERPINA1 alleles identified through a large alpha-1 antitrypsin deficiency screening program and review of known variants

GS Wiesemann, RA Oshins, TO Flagg… - … Diseases: Journal of …, 2022 - pmc.ncbi.nlm.nih.gov
The SERPINA1 gene encodes the serine protease inhibitor alpha-1 antitrypsin (AAT) and is
located on chromosome 14q31-32.3 in a cluster of homologous genes likely formed by exon …

High-resolution ex vivo NMR spectroscopy of human Z α1-antitrypsin

AM Jagger, CA Waudby, JA Irving… - Nature …, 2020 - nature.com
Genetic mutations predispose the serine protease inhibitor α1-antitrypsin to misfolding and
polymerisation within hepatocytes, causing liver disease and chronic obstructive pulmonary …

Real‐world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha‐1‐antitrypsin deficiency

E Giacopuzzi, M Laffranchi, R Berardelli… - Human …, 2018 - Wiley Online Library
The growth of publicly available data informing upon genetic variations, mechanisms of
disease, and disease subphenotypes offers great potential for personalized medicine …

Impact of the PEG length and PEGylation site on the structural, thermodynamic, thermal, and proteolytic stability of mono‐PEGylated alpha‐1 antitrypsin

X Liu, KGW Kouassi, R Vanbever… - Protein …, 2022 - Wiley Online Library
Conjugation to polyethylene glycol (PEG) is a widely used approach to improve the
therapeutic value of proteins essentially by prolonging their body residence time. PEGylation …